project id: TCGA-PAAD; case submitter id: TCGA-HZ-A4BK; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.07; rna integrity number: 7.5; age at index: 72; days to birth: -26503; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 26503; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 657.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 81; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-HZ-A4BK-01A-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 2.0; percent necrosis: 3.0; percent neutrophil infiltration: 2.0; percent normal cells: 20.0; percent stromal cells: 47.0; percent tumor cells: 30.0; percent tumor nuclei: 45.0;